4/A

PRIMARY DOCUMENT

Company: LEXICON PHARMACEUTICALS, INC.
Filed: May 1, 2012
Period of Report: April 27, 2012
Accession Number: 0001127602-12-015176

View Document ↗ View on SEC.gov ↗